We discovered a series of azole antifungal compounds as effective antiprotozoal agents. They displayed promising inhibitory activities within the micromolar-submicromolar range against P. falciparum, L. donovani, and T. b. rhodesiense. Moreover, most of such compounds showed excellent nanomolar IC50against T. cruzi, showing also very low cytotoxicity. Discussion of structure-activity relationships and biological data for these compounds are provided against the different parasites. To assess the mechanism of action against T. cruzi we proved that the most potent compounds (3b, 3j-l) inhibited the T. cruzi CYP51. Moreover, the most active derivative 3j dramatically reduced parasitemia in T. cruzi mouse model without acute toxicity.

Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents / Saccoliti, Francesco; Madia, VALENTINA NOEMI; Tudino, Valeria; DE LEO, Alessandro; Pescatori, Luca; Messore, Antonella; DE VITA, Daniela; Scipione, Luigi; Brun, Reto; Kaiser, Marcel; Mäser, Pascal; Magalhaes Calvet, Claudia; K Jennings, Gareth; M Podust, Larissa; Costi, Roberta; DI SANTO, Roberto. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 156:(2018), pp. 53-60. [10.1016/j.ejmech.2018.06.063]

Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents

Francesco Saccoliti;Valentina Noemi Madia;Valeria Tudino;Alessandro De Leo;Luca Pescatori;Antonella Messore;Daniela De Vita;Luigi Scipione;Roberta Costi;Roberto Di Santo
2018

Abstract

We discovered a series of azole antifungal compounds as effective antiprotozoal agents. They displayed promising inhibitory activities within the micromolar-submicromolar range against P. falciparum, L. donovani, and T. b. rhodesiense. Moreover, most of such compounds showed excellent nanomolar IC50against T. cruzi, showing also very low cytotoxicity. Discussion of structure-activity relationships and biological data for these compounds are provided against the different parasites. To assess the mechanism of action against T. cruzi we proved that the most potent compounds (3b, 3j-l) inhibited the T. cruzi CYP51. Moreover, the most active derivative 3j dramatically reduced parasitemia in T. cruzi mouse model without acute toxicity.
2018
AHRQMVNBLZIKPR-UHFFFAOYSA-N; antifungal; antileishmanial; antiplasmodial; antitrypanosomal; zole; BHLRUOGOYQUJHE-UHFFFAOYSA-N; BKAGEDZBILNZHR-UHFFFAOYSA-N; BTKUBELCONMVFQ-UHFFFAOYSA-N; CYP51; DBDGQVVQYMKPAS-UHFFFAOYSA-N; DIYSLQICFHBTQL-UHFFFAOYSA-N; DULCCGQQCJNKEM-UHFFFAOYSA-N; FXVBCYIZDNNSCJ-UHFFFAOYSA-N; GDTOFSFBQOMDHZ-UHFFFAOYSA-N; GGBXYXPRVQOMBV-UHFFFAOYSA-N; in vivo studies; JCDQIFZYGBRUER-UHFFFAOYSA-N; JMNHBCQWFJFBQW-UHFFFAOYSA-N; NBHPUKZRPYQEGR-UHFFFAOYSA-N; PBNJEFLDXFIGNG-UHFFFAOYSA-N; RGSRKBHTUUKVTA-UHFFFAOYSA-N; UEQSTADAVQNNDM-UHFFFAOYSA-N; VOZKRUYNVQHSHL-UHFFFAOYSA-N; VZFXJIQTDMSFFQ-UHFFFAOYSA-N; YKBDGMCRYYLJKW-UHFFFAOYSA-N; YXTSXRAOMZGEAR-UHFFFAOYSA-N; animals; antiprotozoal agents; cell line; chagas disease; female; humans; imidazoles; inhibitory concentration 50; leishmania donovani; leishmaniasis visceral; malaria; Falciparum; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Structure-Activity Relationship; Trypanosoma brucei rhodesiense; Trypanosoma cruzi; Trypanosomiasis, African; Pharmacology; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry
01 Pubblicazione su rivista::01a Articolo in rivista
Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents / Saccoliti, Francesco; Madia, VALENTINA NOEMI; Tudino, Valeria; DE LEO, Alessandro; Pescatori, Luca; Messore, Antonella; DE VITA, Daniela; Scipione, Luigi; Brun, Reto; Kaiser, Marcel; Mäser, Pascal; Magalhaes Calvet, Claudia; K Jennings, Gareth; M Podust, Larissa; Costi, Roberta; DI SANTO, Roberto. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 156:(2018), pp. 53-60. [10.1016/j.ejmech.2018.06.063]
File allegati a questo prodotto
File Dimensione Formato  
Saccoliti_Biological-evaluation_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 708.59 kB
Formato Adobe PDF
708.59 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1176720
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 16
social impact